Clinical Trial Update: Bioequivalence Study of 3 New Formulations of Premarin/MPA Compared With Premarin/MPA (Prempro) [Phase 1]

View source ↗

Summary

Phase 1 bioequivalence study evaluating three new Premarin/medroxyprogesterone acetate formulations against Premarin/MPA (Prempro) in postmenopausal women; stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postmenopause

Drugs mentioned

• Premarin/Medroxyprogesterone Acetate (Prempro) (conjugated estrogens/medroxyprogesterone acetate)

Snippet

Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer | Conditions: Postmenopause | Phase 1 | Status: COMPLETED